{"title":"Unwanted Immunogenicity: From Risk Assessment to Risk Management","authors":"C. Scott","doi":"10.1201/B22372-28","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":142266,"journal":{"name":"Immune Aspects of Biopharmaceuticals and Nanomedicines","volume":"82 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immune Aspects of Biopharmaceuticals and Nanomedicines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1201/B22372-28","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}